Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | NAAA | Q02083 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | LTA4H | P09960 | 1/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.33 |
| ▸ | ANPEP | P15144 | 1/20 | 0.33 |
| ▸ | LAP3 | P28838 | 1/20 | 0.33 |
| ▸ | NPEPPS | P55786 | 1/20 | 0.33 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.33 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18175919 | 0.98 | EPHX1 (0.41) | EPHX1L3MBTL1CYP19A1CYP2C19NAAA | |
| SCHEMBL28177087 | 0.94 | L3MBTL1 (0.37) | EPHX1L3MBTL1CYP19A1CYP2C19NAAA | |
| SCHEMBL28177085 | 0.89 | OR51E2 (0.40) | EPHX1L3MBTL1CYP19A1CYP2C19OR51E2 | |
| SCHEMBL2256215 | 0.84 | EPHX1 (0.50) | EPHX1L3MBTL1CYP19A1CYP2C19NAAA | |
| SCHEMBL5050113 | 0.82 | CYP2C19 (0.50) | EPHX1L3MBTL1CYP19A1CYP2C19NAAA | |
| SCHEMBL5050116 | 0.82 | L3MBTL1 (0.54) | EPHX1L3MBTL1CYP19A1CYP2C19NAAA | |
| SCHEMBL23698922 | 0.82 | NAAA (0.52) | EPHX1L3MBTL1NAAA | |
| SCHEMBL3013650 | 0.81 | NAAA (0.47) | EPHX1L3MBTL1CYP19A1CYP2C19NAAA | |
| SCHEMBL27754758 | 0.81 | CYP19A1 (0.49) | EPHX1L3MBTL1CYP19A1CYP2C19NAAA | |
| SCHEMBL28931781 | 0.80 | EPHX1 (0.47) | EPHX1L3MBTL1CYP19A1CYP2C19NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12453685-B2 | Method of improving foamability and foam quality of cleaning agent composition, and method of cleaning skin or hair | ADEKA CORPORATION (JP) | 2025-10-28 | — | — | US | claimed |
| EP-3858326-B1 | PRODUCTION METHOD FOR GLYCERYL ETHER-CONTAINING COMPOSITION | ADEKA CORP (JP) | 2025-06-04 | — | — | EP | claimed |
| US-11918668-B2 | Method for producing glyceryl ether-containing composition, and glyceryl ether-containing composition | ADEKA CORPORATION (JP) | 2024-03-05 | — | — | US | claimed |
| US-20230181436-A1 | METHOD OF IMPROVING FOAMABILITY AND FOAM QUALITY OF CLEANING AGENT COMPOSITION, AND METHOD OF CLEANING SKIN OR HAIR | ADEKA CORPORATION (JP) | 2023-06-15 | — | — | US | claimed |
| EP-4183452-A1 | METHOD FOR IMPROVING EFFERVESCENCE AND FOAM QUALITY OF CLEANING AGENT COMPOSITION, AND METHOD FOR CLEANING SKIN OR HAIR | ADEKA CORPORATION (JP) | 2023-05-24 | — | — | EP | claimed |
| EP-3603609-B1 | COSMETIC EMULSION COMPOSITION | ADEKA CORP (JP) | 2022-04-13 | — | — | EP | claimed |
| US-20210353515-A1 | METHOD FOR PRODUCING GLYCERYL ETHER-CONTAINING COMPOSITION, AND GLYCERYL ETHER-CONTAINING COMPOSITION | ADEKA CORPORATION (JP) | 2021-11-18 | — | — | US | claimed |
| US-20210322289-A1 | SYNERGISTICALLY-ACTING COMPOSITIONS FOR MICROBE REDUCTION THAT COMPRISE AROMATIC ALCOHOL, GLYCERYL ETHER AND BISPYRIDINIUM ALKANE AND USE OF SUCH COMPOSITIONS | Schülke & Mayr GmbH (DE) | 2021-10-21 | — | — | US | claimed |
| EP-3858326-A1 | PRODUCTION METHOD FOR GLYCERYL ETHER-CONTAINING COMPOSITION, AND GLYCERYL ETHER-CONTAINING COMPOSITION | ADEKA CORPORATION (JP) | 2021-08-04 | — | — | EP | claimed |
| EP-3849501-A1 | SYNERGISTICALLY-ACTING COMPOSITIONS FOR MICROBE REDUCTION THAT COMPRISE AROMATIC ALCOHOL, GLYCERYL ETHER AND BISPYRIDINIUM ALKANE AND USE OF SUCH COMPOSITIONS | SCHÜLKE & MAYR GmbH (DE) | 2021-07-21 | — | — | EP | claimed |
| WO-2020189365-A1 | HAIR DYE COMPOSITION | 株式会社ADEKA | 2020-09-24 | — | — | WO | claimed |
| WO-2020066893-A1 | PRODUCTION METHOD FOR GLYCERYL ETHER-CONTAINING COMPOSITION, AND GLYCERYL ETHER-CONTAINING COMPOSITION | 株式会社ADEKA | 2020-04-02 | — | — | WO | claimed |
| WO-2020043372-A1 | SYNERGISTICALLY-ACTING COMPOSITIONS FOR MICROBE REDUCTION THAT COMPRISE AROMATIC ALCOHOL, GLYCERYL ETHER AND BISPYRIDINIUM ALKANE AND USE OF SUCH COMPOSITIONS | Schülke & Mayr GmbH (DE) | 2020-03-05 | — | — | WO | claimed |
| EP-3603609-A1 | COSMETIC EMULSION COMPOSITION | ADEKA CORPORATION (JP) | 2020-02-05 | — | — | EP | claimed |
| EP-3111918-B1 | SKIN COSMETIC COMPOSITION, ANTIBACTERIAL AGENT FOR SKIN COSMETIC, AND METHOD FOR ENHANCING ANTIBACTERIAL EFFECT OF DIOL COMPOUND | ADEKA CORP (JP) | 2019-08-14 | — | — | EP | claimed |
| US-10137069-B2 | Skin cosmetic composition, antibacterial agent for skin cosmetic, and method for enhancing antibacterial effect of diol compound | ADEKA CORPORATION (JP) | 2018-11-27 | — | — | US | claimed |
| EP-3111918-A1 | SKIN COSMETIC COMPOSITION, ANTIBACTERIAL AGENT FOR SKIN COSMETIC, AND METHOD FOR ENHANCING ANTIBACTERIAL EFFECT OF DIOL COMPOUND | Adeka Corporation (JP) | 2017-01-04 | — | — | EP | claimed |
| US-20160354291-A1 | SKIN COSMETIC COMPOSITION, ANTIBACTERIAL AGENT FOR SKIN COSMETIC, AND METHOD FOR ENHANCING ANTIBACTERIAL EFFECT OF DIOL COMPOUND | ADEKA CORPORATION (JP) | 2016-12-08 | — | — | US | claimed |
| EP-3578161-B1 | METHOD FOR IMPROVING STORAGE STABILITY OF COSMETIC | ADEKA CORP (JP) | 2025-11-12 | — | — | EP | disclosed |
| WO-2015125392-A1 | SKIN COSMETIC COMPOSITION, ANTIBACTERIAL AGENT FOR SKIN COSMETIC, AND METHOD FOR ENHANCING ANTIBACTERIAL EFFECT OF DIOL COMPOUND | 株式会社ADEKA | 2015-08-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210322289-A1 | SYNERGISTICALLY-ACTING COMPOSITIONS FOR MICROBE REDUCTION THAT COMPRISE AROMATIC ALCOHOL, GLYCERYL ETHER AND BISPYRIDINIUM ALKANE AND USE OF SUCH COMPOSITIONS | MGLL, ADH5, GK | EPHX1 1695/4885L3MBTL1 2841/4885CYP19A1 1803/4885 |
| US-10137069-B2 | Skin cosmetic composition, antibacterial agent for skin cosmetic, and method for enhancing antibacterial effect of diol compound | CUTA, PHGDH, GCDH | EPHX1 1598/4885L3MBTL1 4807/4885CYP19A1 929/4885 |
| US-20160354291-A1 | SKIN COSMETIC COMPOSITION, ANTIBACTERIAL AGENT FOR SKIN COSMETIC, AND METHOD FOR ENHANCING ANTIBACTERIAL EFFECT OF DIOL COMPOUND | CUTA, PHGDH, GCDH | EPHX1 1598/4885L3MBTL1 4807/4885CYP19A1 929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.